❮ Back to Researchers

Michelle Sholzberg

MDCM, MSc, FRCPC

Scientist, Keenan Research Centre for Biomedical Science (KRCBS)

Email: Michelle.Sholzberg@unityhealth.to
Tel: 416-864-6060 x5389

Biography

Dr. Michelle Sholzberg received her MDCM and residency training in Internal Medicine at McGill University, completed additional postgraduate training in Hematology at the University of Toronto and a research hemostasis fellowship in Toronto and internationally. Dr. Sholzberg has a Master of Science from the University of Toronto in Clinical Epidemiology and Health Care Research and was awarded the Claire Bombardier award for career promise as a scientist. She is a clinician-scientist with a focus on coagulation, the Division Head of Hematology-Oncology and the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital. She is also the Director of the Hematology-Oncology Clinical Research Group and Co-director of the Hematology-Immunology Translational Research Theme of the Li Ka Shing Knowledge Institute. Currently, she is involved in the study of: prediction tools for perioperative and traumatic bleeding, the intersection of women’s health and bleeding disorders, treatments for iron deficiency anemia, new treatments for immune thrombocytopenia and the management of COVID-19 coagulopathy.

Recent Publications

  1. Ocran, E, Chornenki, NLJ, Bowman, M, Sholzberg, M, James, P. Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations. Expert Rev Hematol. 2023; :. doi: 10.1080/17474086.2023.2221846. PubMed PMID:37278227 .
  2. Bogler, O, Raissi, A, Colacci, M, Beaman, A, Biering-Sørensen, T, Cressman, A et al.. Association Between Diabetes and Mortality Among Adult Patients Hospitalized With COVID-19: A Cohort Study of Hospitalized Adults in Ontario, Canada, and Copenhagen, Denmark. Can J Diabetes. 2023; :. doi: 10.1016/j.jcjd.2023.02.005. PubMed PMID:37074240 PubMed Central PMC9946865.
  3. Merz, LE, Siad, FM, Creary, M, Sholzberg, M, Weyand, AC. Laboratory-based inequity in thrombosis and hemostasis: review of the evidence. Res Pract Thromb Haemost. 2023;7 (2):100117. doi: 10.1016/j.rpth.2023.100117. PubMed PMID:37063772 PubMed Central PMC10099330.
  4. Mahamad, S, Modi, D, Al-Samkari, H, Cuker, A, Despotovic, JM, Italiano, JE et al.. Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management. Res Pract Thromb Haemost. 2023;7 (2):100097. doi: 10.1016/j.rpth.2023.100097. PubMed PMID:37063755 PubMed Central PMC10099320.
  5. Lin, Y, Del Giudice, ME, Kron, A, Meirovich, H, Sholzberg, M, Swarup, V et al.. A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia. Br J Haematol. 2023;201 (5):1000-1004. doi: 10.1111/bjh.18792. PubMed PMID:36999886 .
  6. Thachil, J, Connors, JM, Mahlangu, J, Sholzberg, M. Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets. J Thromb Haemost. 2023; :. doi: 10.1016/j.jtha.2023.03.016. PubMed PMID:36972786 .
  7. Naveed, K, Goldberg, N, Shore, E, Dhoot, A, Gabrielson, D, Goodarzi, Z et al.. Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study. Int J Lab Hematol. 2023;45 (3):377-386. doi: 10.1111/ijlh.14016. PubMed PMID:36602151 .
  8. Tse, B, Nisenbaum, R, Floros, G, Jiwajee, A, Teitel, J, Sholzberg, M et al.. Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgery. J Thromb Thrombolysis. 2023;55 (2):273-281. doi: 10.1007/s11239-022-02741-2. PubMed PMID:36547766 .
  9. Khadadah, F, Gabarin, N, Jiwajee, A, Nisenbaum, R, Hanif, H, James, P et al.. Reducing use of coagulation tests in a family medicine practice setting: An implementation study. Res Pract Thromb Haemost. 2022;6 (8):e12843. doi: 10.1002/rth2.12843. PubMed PMID:36514345 PubMed Central PMC9732811.
  10. VanderMeulen, H, Arya, S, Nersesian, S, Philbert, N, Sholzberg, M. What have we learned about the patient's experience of von Willebrand disease? A focus on women. Hematology Am Soc Hematol Educ Program. 2022;2022 (1):631-636. doi: 10.1182/hematology.2022000391. PubMed PMID:36485077 PubMed Central PMC9820129.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Division of Hematology, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto